Rijnstate Ziekenhuis
Hospital
Location:
Arnhem / Zevenaar / Velp,
Netherlands (NL)
ISNI: -
ROR: https://ror.org/0561z8p38
Show on Map:
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022)
Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al.
Journal article
PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021)
Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al.
Conference contribution
Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020)
Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al.
Conference contribution